Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
33. Polypharmacy and Overdose
33. Polypharmacy and Overdose
33. Polypharmacy and Overdose
Monday 4th December 2023
Join Drs. Del Tredici and Keenan as they explore overdose risks tied to polypharmacy, challenging existing clinical practices in this episode.
35 minutes
Thought-provoking
Informative
Challenging
Engaging
Supportive
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
56 (View all)
Do you want to link to this podcast?
Get the buttons here!Rethinking Overdose Risks: Polypharmacy and Clinical Practices
Episode Overview
- The episode delves into a thought-provoking study on overdose risk and polypharmacy
- The hosts discuss the article's implications for patient care and their own prescribing patterns
- The in-depth analysis fosters an engaging and informative conversation
- Surprising findings challenge previous assumptions, inviting listeners to reconsider their own practices
I love these kind of articles that force me to think about things a little differently.
Ever wondered how combining medications can impact overdose risks? In this episode of the 'Addiction Medicine Journal Club,' Dr. Sonya Del Tredici and Dr. John Keenan dive into the intricate world of polypharmacy. They dissect a recent study that examines the overdose risks associated with prescribing opioid agonists alongside other medications like benzodiazepines, antipsychotics, and gabapentinoids. This isn't just a dry academic discussion; the hosts share their own experiences and how these findings have challenged their existing prescribing habits.
You'll find yourself questioning your own assumptions about medication management and patient safety. But that's not all. The episode also touches on treating HIV in primary care settings and whether removing prior authorization barriers for buprenorphine impacts prescribing rates. These topics are crucial for anyone involved in addiction medicine or primary care, offering practical insights that you can apply in your own practice. Dr. Del Tredici and Dr.
Keenan bring a wealth of experience and a touch of humor to the table, making complex topics accessible and engaging. Whether you're a seasoned healthcare professional or someone keen on understanding the latest in addiction medicine, this episode is packed with valuable takeaways. So grab your headphones and get ready to rethink what you know about polypharmacy and overdose risks.